I'm dissapointed, but not surprised with the delay
Post# of 148302
1) Basket Trial started. This could get us to 30 patients, with data in 60 days
2) Possible licensing deal. I hope they PR it soon, and there is a hefty upfront payment that cures our money woes. This would also propel the SP.
3) Note holders done selling. This takes the lid off the price. When the next catalyst hits the upward move should be strong.
We just need to keep making progress. But I for one will breath a sigh of relief when bla is submitted, and an even bigger one when FDA responds to our BTD request.